Transsphenoidal surgery is an operation that reaches the pituitary gland through the nose and a bone cavity behind it called the sphenoid sinus, avoiding the need to open the skull. It is the standard surgical approach for pituitary tumors and a small number of other growths near the base of the brain. The procedure takes its name from the route: “trans” (through) the “sphenoid” (the butterfly-shaped bone that houses the sinus sitting just below the pituitary gland).
How the Surgical Route Works
The pituitary gland sits in a small bony cradle at the base of the skull, directly above the sphenoid sinus. That sinus is essentially a hollow pocket inside the sphenoid bone, accessible from the back of the nasal cavity. Surgeons take advantage of this natural corridor. They enter through one or both nostrils, pass along the nasal septum, open the front wall of the sphenoid sinus, then go through the thin bone at the top of the sinus to reach the pituitary.
The key landmark guiding the surgeon is the opening of the sphenoid sinus, visible in about 53% of patients once the middle turbinate (a shelf of tissue on the side wall of the nose) is pushed aside. From there, bone landmarks on the sphenoid itself confirm the correct path. Because the entire route follows existing air-filled spaces, there is no need to cut through brain tissue.
Endoscopic vs. Microscopic Techniques
Two main versions of this surgery exist, and the difference comes down to how the surgeon sees what they’re doing. The microscopic approach uses an operating microscope positioned outside the nose, looking down a narrow corridor held open by a nasal speculum. The endoscopic approach threads a small camera directly into the nasal cavity, giving the surgeon a wide, panoramic view on a monitor.
The endoscope sees around corners that a microscope cannot. It provides better visualization of structures off to the side, like the walls of the cavernous sinuses that run alongside the pituitary. It also tends to cause less damage to nasal tissue because it doesn’t require a speculum, sublabial incisions, or lifting of the septal lining. Many centers have shifted toward the endoscopic technique, though both remain in use and produce good outcomes.
Conditions Treated With This Approach
Pituitary adenomas are by far the most common reason for transsphenoidal surgery. These benign tumors fall into two categories. Non-functioning adenomas don’t produce excess hormones but can grow large enough to press on the optic nerves, causing loss of peripheral vision. Surgery is recommended when they cause visual problems or keep growing on follow-up MRI scans.
Functioning adenomas overproduce specific hormones, leading to conditions like Cushing’s disease (too much cortisol), acromegaly (too much growth hormone), or hormone imbalances that cause menstrual irregularities and infertility. Surgery is often the first-line treatment for these. In a separate, urgent scenario called pituitary apoplexy, sudden bleeding or swelling inside a pituitary tumor causes severe headache and rapid vision loss, requiring emergency surgery.
Less commonly, the approach is used for other growths near the pituitary, including craniopharyngiomas, meningiomas, chordomas, and occasionally metastatic tumors that have spread to this area.
What Happens Before Surgery
Preoperative planning centers on two things: detailed imaging and a full hormonal workup. High-resolution MRI is the standard, with image slices spaced just 1 to 2 millimeters apart through the pituitary region. A contrast dye (gadolinium) is injected during the scan to distinguish tumor tissue from normal gland and nearby blood vessels. Surgeons also look carefully at whether the tumor has pushed into the cavernous sinuses on either side, which affects how much can safely be removed. In some cases, a CT scan supplements the MRI to map the bony anatomy of the sphenoid sinus.
Blood tests measure levels of all the hormones the pituitary controls: cortisol, thyroid hormone, sex hormones, growth hormone, and prolactin. These baseline values help the surgical team plan for any hormone support needed during and after the operation, and they serve as a comparison point for recovery.
Success and Remission Rates
For Cushing’s disease, experienced surgical centers report long-term remission rates averaging 80% overall. When the tumor is a small, well-defined microadenoma that hasn’t invaded surrounding tissue, that number rises to about 90%. Across more than 3,000 patients in published studies since 1995, remission rates ranged from 69% to 98%, with surgical mortality consistently below 1%.
For patients whose pituitary tumor was pressing on the optic nerves, visual field defects improve in 75% to 100% of cases after successful decompression. In more than half of patients, vision continues to get better over the full first year following surgery rather than plateauing right away.
Risks and Complications
The most closely tracked complication is a cerebrospinal fluid (CSF) leak, where the protective fluid surrounding the brain drips through the surgical opening into the nose. A large meta-analysis found this occurs in about 3.4% of transsphenoidal surgeries. A CSF leak matters because it can lead to meningitis or other infections if not repaired, and it sometimes requires a second procedure to seal the opening.
Diabetes insipidus is another well-known risk. This is not related to blood sugar. It happens when the surgery disrupts the pituitary’s ability to produce a hormone that controls water balance, leading to excessive urination and thirst. In many cases this is temporary, resolving within days to weeks, but it occasionally becomes permanent and requires ongoing medication. Other potential complications include new hormone deficiencies, nasal bleeding, and, rarely, damage to surrounding structures like the carotid arteries or optic nerves.
Recovery Timeline
The average hospital stay is about 4 to 5 days. During that time, the medical team monitors hormone levels, checks for signs of a CSF leak, and watches fluid balance for early diabetes insipidus. Most patients feel congested and have mild headaches for the first week or two, similar to a bad sinus infection.
Specific activity restrictions protect the healing surgical site. You’ll typically be told to avoid blowing your nose, bending forward to wash your hair, heavy lifting (anything over about 10 kilograms), sneezing with your mouth closed, and flying for one to three months. In practice, patients in one study returned to nose blowing at a median of 44 days, heavy lifting at 59 days, and washing hair with the head tilted down at 64 days. Sexual activity took a median of about 102 days to resume. These timelines vary, but they give a realistic picture of the recovery arc.
Hormone Monitoring After Surgery
The first full check of pituitary hormone function typically happens 4 to 6 weeks after surgery. This blood work looks at cortisol, thyroid function, sex hormones, and growth hormone levels to determine which, if any, need replacement.
Cortisol deficiency is the most immediately important to catch, since the body cannot handle stress without adequate cortisol. If cortisol production was already impaired before surgery, lifelong replacement is very likely. Thyroid hormone replacement, if needed, is adjusted based on free T4 levels in the blood (TSH, the usual thyroid screening test, is unreliable when the problem originates in the pituitary). Sex hormone replacement depends on whether fertility is a goal: testosterone for men or estrogen for women when it isn’t, and a different hormonal approach when it is. Growth hormone deficiency is assessed separately and treated with daily injections if confirmed.
Some of these deficits are temporary. Thyroid function, for example, has been shown to recover more at one year than at three months. Others, particularly cortisol deficiency that existed before surgery, tend to be permanent.
Long-Term Recurrence
Even after successful removal, pituitary tumors can regrow. For non-functioning adenomas, recurrence rates after surgery climb gradually over time: roughly 2% at two years, 9% at five years, and 17% at ten years. This slow timeline is why long-term follow-up with periodic MRI scans is standard. Visual field testing is also repeated, generally starting at least three months after surgery, to confirm that decompression of the optic nerves is holding. If a tumor does recur, repeat transsphenoidal surgery, radiation therapy, or both are options depending on the size and location of the regrowth.